Business, Policy & Funding
Breaking news on diagnostics business, policy, and funding.
Roche Preeclampsia Assay Nabs FDA 510(k) Clearance
The prognostic test stratifies hospitalized women with hypertensive disorders of pregnancy into low- and high-risk categories for developing severe preeclampsia.
QuidelOrtho Q4 Revenues Dip 5 Percent, Beat Estimates
For 2025, the company guided to total revenues of $2.60 billion to $2.81 billion and adjusted EPS of $2.07 to $2.57.
Genomictree Closing in on South Korea Approval for Bladder Cancer MDx, Aims to Begin US Trials Soon
Premium
Recent study results show that the single-target DNA methylation test performed with a negative predictive value of 97.6 percent.
Craig-Hallum Initiates Coverage of Myriad Genetics With a Buy Rating
Craig-Hallum expects stable Prolaris revenues and sees opportunities for significant growth in the hereditary cancer and prenatal testing markets.
Adaptive Bio 'Confident' of MRD Reaching Profitability in 2025 as Q4 Revenues Rise 4 Percent
Premium
The Seattle-based firm booked $47.5 million in revenues during the fourth quarter while full-year revenues grew 5 percent to $179.0 million.